Two new drugs declared by Huahai pharmaceutical and Huabei pharmaceutical failed to pass the examination
-
Last Update: 2014-11-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The Policresulen Gel of arihua and Huarun of Shuanghua pharmaceutical company entered the approval process It is understood that aripiprazole is a kind of drug for the treatment of schizophrenia, which belongs to the third generation of atypical antipsychotic drugs At present, there are Shanghai Zhongxi, Chengdu Kanghong and other companies in China Policresulen Gel is mainly used for gynecologic cervicitis, vulvar itching, cervical polyps and so on At present, Chengdu is mainly in the production of crane mountain The pidomode oral solution of Dikang Pharmaceutical Co., Ltd has passed the examination and approval It is mainly used for acute bronchitis, rhinitis, sinusitis, otitis media, pharyngitis, etc at present, it is mainly produced by Suzhou Changzheng Xinkai However, lisinopril hydrochlorothiazide tablets declared by Huahai pharmaceutical and loratadine orally disintegrating tablets declared by Huabei pharmaceutical were not approved by the State Drug Administration.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
